Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US11439610 | EVOFEM INC | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
Mar, 2033
(10 years from now) | |
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6706276 | EVOFEM INC | Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
Mar, 2023
(a month from now) | |
US10568855 | EVOFEM INC | Compositions and methods for enhancing the efficacy of contraceptive microbicides |
Mar, 2033
(10 years from now) | |
US11337989 | EVOFEM INC | Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound |
Mar, 2033
(10 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
New Product (NP) | May 22, 2023 |
Drugs and Companies using CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE ingredient
Market Authorisation Date: 22 May, 2020
Treatment: Prevention of pregnancy
Dosage: GEL;VAGINAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic